Edition:
United Kingdom

People: Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

193.95INR
24 May 2019
Change (% chg)

Rs1.30 (+0.67%)
Prev Close
Rs192.65
Open
Rs195.15
Day's High
Rs197.45
Day's Low
Rs191.45
Volume
34,316
Avg. Vol
98,063
52-wk High
Rs288.25
52-wk Low
Rs137.75

Jain, Rajesh 

Dr. Rajesh Jain is Managing Director, Executive Director of the Company. He was Joint Managing Director of Panacea Biotec Ltd. Dr. Jain is a holder of Ph.D. in Business Administration (Commerce), a Post Graduate degree in Business Management from Shivaji Institute of Management, Ghaziabad, India and is science graduate from University of Delhi. Dr. Rajesh Jain is in the supervision of day-to-day operations with emphasis on Research & Development, business development and marketing. Under his understanding of the business mantras, the Company has an impressive product pipeline and is targeting key therapeutic areas that will deliver new and innovative treatment therapies. As a result of his unlimited energy and enthusiasm, the company has been ranked the vaccine producer in India and has been ranked as the 3rd biotechnology Company (Able Survey 2011).

Basic Compensation

Total Annual Compensation, INR 7,075,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 7,075,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Soshil Jain

8,032,000

Devender Gupta

--

Vinod Goel

--

Rajesh Jain

7,075,000

Sandeep Jain

6,456,000

Ankesh Jain

--
As Of  31 Mar 2014